Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Diagnostic delay (DD) is a common finding in inflammatory bowel diseases (IBD). The reasons and effects of this delay are frequently underestimated, particularly in the context of sex. Our aims were to examine the impact of delayed diagnosis in IBD, with a particular focus on sex disparities.
Methods: We performed a single-center, cross-sectional study at a tertiary referral center, including patients with IBD. The data was collected between August 2020 and June 2024.
Results: A total of 247 individuals with IBD were included in this study, with 53% identifying as female and 51% having Crohn's disease. Probability estimators revealed an effect of a DD on the cumulative advanced drug therapy probability in women (p = 0.045). Further analysis of the interaction between therapeutic regimens and DD revealed significant differences between the sexes. Women with a longer latency in their diagnosis were more frequently treated with steroids only compared to men. Entity-specific DD was further identified as a risk factor for steroid-only treatment in women with IBD (OR: 2.6; 95% CI, 1.11-5.98; = .028). Additionally, a notable disparity in quality of life was observed between women who exhibited DD and men, with the former demonstrating a significantly reduced quality of life.
Conclusions: A delayed diagnosis has a significant impact on IBD treatment trajectories, with a notable sex-related effect observed especially in women. Therapeutic needs in female patients with IBD seem underestimated, particularly in instances where a DD is present.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12260162 | PMC |
| http://dx.doi.org/10.1093/crocol/otaf040 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
DNA methylation subtypes dictate metastatic heterogeneity of osteosarcoma via distinct tumor-stromal interactions: Multi-omics profiling and decitabine validation.
Int J Biol Macromol
September 2025
Faculty of Applied Sciences, Macao Polytechnic University, Macao. Electronic address:
Osteosarcoma (OS), the most prevalent primary bone malignancy in adolescents, is characterized by aggressive progression and early metastasis. However, the epigenetic drivers of its metastatic heterogeneity remain poorly understood. Herein, we integrated bulk DNA methylation profiling and single-cell RNA sequencing (scRNA-seq) to elucidate the epigenetic mechanisms driving OS metastatic heterogeneity.
View Article and Find Full Text PDFAccelerated Patient-specific Non-Cartesian MRI Reconstruction using Implicit Neural Representations.
Int J Radiat Oncol Biol Phys
September 2025
Radiation Oncology, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143. Electronic address:
Purpose: Accelerating MR acquisition is essential for image guided therapeutic applications. Compressed sensing (CS) has been developed to minimize image artifacts in accelerated scans, but the required iterative reconstruction is computationally complex and difficult to generalize. Convolutional neural networks (CNNs)/Transformers-based deep learning (DL) methods emerged as a faster alternative but face challenges in modeling continuous k-space, a problem amplified with non-Cartesian sampling commonly used in accelerated acquisition.
View Article and Find Full Text PDFPrediction of cognitive decline and Alzheimer's disease conversion by a plasma biomarker panel in non-demented individuals.
Geroscience
September 2025
Department of Biological Sciences, College of Natural Sciences, Kangwon National University, Kangwon, 24341, Republic of Korea.
Alzheimer's disease (AD) represents a growing global health burden, underscoring the urgent need for reliable diagnostic and prognostic biomarkers. Although several disease-modifying treatments have recently become available, their effects remain limited, as they primarily delay rather than halt disease progression. Thus, the early and accurate identification of individuals at elevated risk for conversion to AD dementia is crucial to maximize the effectiveness of these therapies and to facilitate timely intervention strategies.
View Article and Find Full Text PDFThe influence of metabolic dysfunction on depressive symptom trajectories: A one-year follow-up study.
J Affect Disord
September 2025
Département de psychiatrie et d'addictologie, Université de Montréal, Montréal, Québec, Canada; Centre de recherche de l'Institut universitaire en santé mentale (CR-IUSMM), Université de Montréal, Montréal, Québec, Canada.
This study explored the role of metabolic syndrome (MetS) and health-related behaviors in the progression of depressive symptoms over a one-year naturalistic follow-up in patients with depressive disorder. Using data from 153 participants recruited through the Signature Biobank at a psychiatric emergency setting, we tested whether MetS mediated the relationship between health-related behaviors such as smoking, alcohol and drug use, and sleep, and depressive symptom trajectories. Linear mixed models revealed that while depressive symptoms significantly decreased over time, higher MetS score was associated with a slower improvement in depressive symptoms.
View Article and Find Full Text PDFA mixed-methods study of communication preferences and experiences from diagnosis to death as reported by patients with advanced cancer and their family caregivers.
Patient Educ Couns
August 2025
Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Objective: To examine how communication needs regarding prognosis, treatment options, and palliative care evolve over time for patients with advanced cancer and their family caregivers, particularly as patients approach the end-of-life.
Methods: This mixed-methods study surveyed 272 patients at a California healthcare system from October 2019-November 2021 at 1, 4, 8, and 12 months after identification of advanced cancer. Additionally, 24 family caregivers were interviewed between March 2021-May 2022.